首页|基于线粒体及铁死亡相关基因构建肾透明细胞癌预后模型及ACADSB的作用机制

基于线粒体及铁死亡相关基因构建肾透明细胞癌预后模型及ACADSB的作用机制

扫码查看
目的 基于线粒体及铁死亡相关基因构建肾透明细胞癌(ccRCC)预后预测模型,探讨与线粒体和铁死亡相关基因ACADSB在ccRCC预后中的价值.方法 使用来自TCGA数据库的ccRCC的RNA测序数据和临床数据,利用Wilcoxon检验获取ccRCC组织与正常组织差异表达的线粒体及铁死亡相关基因,通过单因素Cox分析、最小绝对值收敛和选择算子(LASSO)分析和多因素Cox分析筛选与生存显著相关的基因并构建预后模型,并评估预后模型在ccRCC中的预测能力.此外,分析核心基因ACADSB在ccRCC中的表达水平、预后预测及生物学功能.在ccRCC细胞系中过表达ACADSB,以研究其对ccRCC细胞体外增殖和迁移能力的影响.结果 利用4个线粒体及铁死亡相关基因(GOT1、BID、ACADSB和PLA2G6)构建ccRCC风险评分预后模型MFrisk,高风险评分组的患者的总生存期明显短于低风险组(P均<0.01).模型预测患者1年、3年和5年生存率的受试者工作特征(ROC)曲线下面积(AUC)在训练集和测试集中分别为0.733、0.771、0.783和0.677、0.607、0.676.在训练集和测试集中,单变量Cox分析及多变量Cox分析(P均<0.01)结果显示MFrisk评分与预后独立明显相关.且基于MFrisk和临床因素构建的列线图同样具有强大的预测性能.此外,对关键基因ACADSB进行研究,细胞计数试剂盒(CCK-8)实验、平板克隆形成实验、划痕愈合实验均证实过表达ACADSB抑制ccRCC细胞增殖和迁移能力.结论 线粒体及铁死亡相关基因GOT1、BID、ACADSB、PLA2G6所构建预后模型可独立预测ccRCC预后;预后模型关键基因ACADSB过表达导致ccRCC细胞增殖和迁移能力下降,为ccRCC治疗策略提供参考.
Building a prognostic model for clear cell renal cell carcinoma based on mitochondrial-and ferrop-tosis-related genes and exploring the mechanism of ACADSB
Objective To construct a prognostic model for clear cell renal cell carcinoma(ccRCC)based on mitochondria-and ferroptosis-related genes,and explore the value of ACADSB,a gene associated with mitochondria and ferroptosis,in ccRCC prognosis.Methods Utilizing RNA-seq and clinical data from the TCGA database,differentially expressed mitochondria-and ferroptosis-related genes between ccRCC and normal tissues were identified using the Wilcoxon test.Through univariate Cox analysis,least absolute value convergence and selection operator(LASSO)analysis and multivariate Cox analysis,genes significantly associated with survival were selected to construct the prognostic model.The prognostic model's predictive ability in ccRCC was assessed.Additionally,the expression level,prognostic predic-tion,and biological function of the core gene ACADSB were analyzed.Overexpression of ACADSB in ccRCC cell lines was conducted to investigate its impact on cell proliferation and migration in vitro.Results A prognostic model(MFrisk)was constructed based on four mitochondria-and ferroptosis-related genes(GOT1,BID,ACADSB,and PLA2G6).Patients in the high-risk group exhibited significantly shorter o-verall survival than the low-risk group(P<0.01 for all comparisons).The model demonstrated strong pre-dictive performance for 1-year,3-year,and 5-year survival rates with area under the receiver operating characteristic(ROC)curve(AUC)of 0.733,0.771,0.783 in the training set,and 0.677,0.607,0.676 in the testing set.Univariate and multivariate Cox analyses(P<0.01 for all comparisons)revealed that the MFrisk score was independently associated with prognosis.Additionally,overexpression of ACADSB was found to inhibit ccRCC cell proliferation and migration in vitro through cell counting kit-8(CCK-8)assay,colony formation assay,and wound-healing assay.Conclusion A prognostic model based on mitochondria-and ferroptosis-related genes(GOT1,BID,ACADSB,PLA2G6)can independently predict ccRCC prognosis.Overexpression of the key gene ACADSB leads to decreased cell proliferation and migration in ccRCC,providing insights for ccRCC treatment strategies.

Clear cell renal cell carcinomaMitochondriaFerroptosisPrognosisBioin-formatics

王君、邱强民、王天宇、郭嘉瑜、邱涛、周江桥

展开 >

武汉大学人民医院器官移植科,武汉 430060

武汉大学人民医院泌尿外科,武汉 430060

肾透明细胞癌 线粒体 铁死亡 预后 生物信息学

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(4)
  • 9